US STOCK
GMAB Stock Analysis
US stocks · market data · technical indicators
Genmab A/S ADS
GMABUS stocksQuote delayed 15 min
10/26 上午11:19 updated
$43.79
+3.79+9.47%
Open
$39.84
High
$44.34
Low
$39.64
Volume
1,300.10萬
GMAB price history
+23.84%Open
35.36
Latest
43.79
High
43.79
Low
34.55
Average
37.43
Advertisement
Financial snapshot
GMAB - Genmab A/S
EPS
1.28USD
Forward EPS
1.52USD
P/E
34.21x
Forward P/E
28.90x
P/B
4.39x
ROE
14.00%
ROA
8.79%
Operating margin
35.24%
Profit margin
19.08%
Revenue growth
24.90%
Earnings growth
-9.40%
Dividend yield
0.00%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.16B | $896.00M | $1.06B | $1.02B | $925.00M | — |
| Gross profit | $1.07B | $831.00M | $977.00M | $964.00M | $868.00M | — |
| Operating income | $407.00M | $225.00M | $243.00M | $459.00M | $360.00M | — |
| Net income | $303.00M | $53.00M | $31.00M | $401.00M | $336.00M | — |
| Basic EPS | 0.49 | 0.08 | — | 0.65 | 0.54 | 0.31 |
| Diluted EPS | 0.49 | 0.08 | — | 0.65 | 0.54 | 0.30 |
Estimates vs actuals
Next earnings
2026-11-05
EPS estimate
—
Revenue estimate
$8.02B
Last surprise
+47.50%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-11-05 | 0.34 | Not reported | — |
| 2026-08-06 | 0.33 | 0.49 | +47.50% |
| 2026-05-07 | 0.19 | 0.13 | -29.74% |
| 2026-02-17 | 0.37 | 0.21 | -44.55% |
| 2025-11-06 | 0.45 | 0.65 | +42.31% |
| 2025-08-07 | 0.34 | 0.54 | +61.37% |
| 2025-05-08 | 0.23 | 0.31 | +34.12% |
| 2025-02-12 | 0.28 | 0.84 | +203.13% |
| 2024-11-06 | 0.33 | 0.29 | -14.65% |
| 2024-08-08 | 0.32 | 0.32 | -0.90% |
| 2024-05-02 | 0.14 | 0.29 | +102.97% |
| 2024-02-14 | 0.30 | 0.14 | -52.91% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| BlackRock Inc. | 2024-06-30 | $127.7M | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $96.6M | 0.13% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $96.3M | 0.07% |
| CITADEL ADVISORS LLC | 2026-06-30 | $68M | 0.01% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$47.12
Target range
$33.50 – $60.00
Implied upside
7.60%
Strong buy
1
Buy
10
Hold
1
Sell
0
Strong sell
0
Advertisement